CONFO Trademark

Trademark Overview


On Monday, November 21, 2022, a trademark application was filed for CONFO with the United States Patent and Trademark Office. The USPTO has given the CONFO trademark a serial number of 97685859. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, November 19, 2024. This trademark is owned by Confo Therapeutics N.V.. The CONFO trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and veterinary preparations for use in oncology and in the field of immunology, namely, pharmaceutical and veterinary preparations for treating immune-related diseases; pharmaceutical and veterinary preparations for the treatment of inflammatory diseases and infections and for the treatment of gastro-intestinal, cardiovascular, pulmonary, neurological, metabolic, systemic, gynecological, urological, dermatological and musculo-skeletal conditions and for the treatment of orphan diseases; chemical and biochemical substances for pharmaceutical and veterinary use in the nature of stabilized protein arrays, namely, small molecules and antibodies for diagnostic purposes for use in oncology and in the field of immunology and for the treatment of inflammatory diseases and infections and for the treatment of gastrointestinal, cardiovascular, pulmonary, neurological, metabolic, systemic, gynecological, urological, dermatological and musculo-skeletal conditions and for the treatmen...

Laboratory chemicals for scientific use; biochemicals for in vitro and in vivo scientific use; biochemical substances, namely, antibodies for stabilization of proteins, all the aforementioned substances for scientific use and for use in laboratories; reagents for medical research; diagnostic preparations for scientific or research use; chemical reagents for use in genetic research; receptors and reagents for testing for G protein-coupled receptors (GPCRs); Chemical substances for use in the production of drugs; Biochemical and chemical substances and chemical reagents for measuring combined or divided natural and non-natural G protein-coupled receptors (GPCRs); Proteins for use in science; Chimeric proteins to measure, test and develop compounds and ligands binding to G protein-coupled receptors (GPCRs)

Medical and pharmacological research services; Pharmaceutical drug development services; Laboratory research services relating to pharmaceuticals; Research and development of vaccines and medicines; Scientific research for medical purposes and the development of pharmaceutical preparations in the area of drugs interacting with G protein-coupled receptors (GPCRs); Design of computer databases; Updating of database software; Data warehousing; Provision of information and data relating to medical research and development; Rendering of computer graphics featuring digital image correction for research and development; Computer graphic design services featuring data and image processing services for making three dimensional models; Non-medical graphic design featuring digital imaging services; Optical imaging for use in research and development of medicines; Imaging via computers for use in research and development of medicines; Graphic design services for generating and processing data and ...

General Information


Serial Number97685859
Word MarkCONFO
Filing DateMonday, November 21, 2022
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, November 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical and veterinary preparations for use in oncology and in the field of immunology, namely, pharmaceutical and veterinary preparations for treating immune-related diseases; pharmaceutical and veterinary preparations for the treatment of inflammatory diseases and infections and for the treatment of gastro-intestinal, cardiovascular, pulmonary, neurological, metabolic, systemic, gynecological, urological, dermatological and musculo-skeletal conditions and for the treatment of orphan diseases; chemical and biochemical substances for pharmaceutical and veterinary use in the nature of stabilized protein arrays, namely, small molecules and antibodies for diagnostic purposes for use in oncology and in the field of immunology and for the treatment of inflammatory diseases and infections and for the treatment of gastrointestinal, cardiovascular, pulmonary, neurological, metabolic, systemic, gynecological, urological, dermatological and musculo-skeletal conditions and for the treatment of orphan diseases; veterinary products, namely, antibody reagents used for the detection of antigens in cells and tissue for medical purposes; veterinary products, namely, antibody reagents for therapeutic use in oncology and in the field of immunology and for the treatment of inflammatory diseases and infections and for the treatment of gastrointestinal, cardiovascular, pulmonary, neurological, metabolic, systemic, gynecological, urological, dermatological and musculo-skeletal conditions and for the treatment of orphan diseases; veterinary products, namely, small molecules in the form of low molecular weight organic compounds; veterinary products, namely, biological preparations for use in oncology and in the field of immunology and for the treatment of inflammatory diseases and infections and for the treatment of gastrointestinal, cardiovascular, pulmonary, neurological, metabolic, systemic, gynecological, urological, dermatological and musculo-skeletal conditions and for the treatment of orphan disease
Translation of Words in MarkThe wording CONFO has no meaning in a foreign language.
Goods and ServicesLaboratory chemicals for scientific use; biochemicals for in vitro and in vivo scientific use; biochemical substances, namely, antibodies for stabilization of proteins, all the aforementioned substances for scientific use and for use in laboratories; reagents for medical research; diagnostic preparations for scientific or research use; chemical reagents for use in genetic research; receptors and reagents for testing for G protein-coupled receptors (GPCRs); Chemical substances for use in the production of drugs; Biochemical and chemical substances and chemical reagents for measuring combined or divided natural and non-natural G protein-coupled receptors (GPCRs); Proteins for use in science; Chimeric proteins to measure, test and develop compounds and ligands binding to G protein-coupled receptors (GPCRs)
Goods and ServicesMedical and pharmacological research services; Pharmaceutical drug development services; Laboratory research services relating to pharmaceuticals; Research and development of vaccines and medicines; Scientific research for medical purposes and the development of pharmaceutical preparations in the area of drugs interacting with G protein-coupled receptors (GPCRs); Design of computer databases; Updating of database software; Data warehousing; Provision of information and data relating to medical research and development; Rendering of computer graphics featuring digital image correction for research and development; Computer graphic design services featuring data and image processing services for making three dimensional models; Non-medical graphic design featuring digital imaging services; Optical imaging for use in research and development of medicines; Imaging via computers for use in research and development of medicines; Graphic design services for generating and processing data and images for making three dimensional models for use in research and development of medicines

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, December 12, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 12, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 12, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameConfo Therapeutics N.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressZwijnaarde 9052
BE

Trademark Events


Event DateEvent Description
Thursday, November 24, 2022NEW APPLICATION ENTERED
Monday, December 12, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 1, 2023ASSIGNED TO EXAMINER
Tuesday, October 24, 2023NON-FINAL ACTION WRITTEN
Tuesday, October 24, 2023NON-FINAL ACTION E-MAILED
Tuesday, October 24, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 23, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, January 23, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, April 22, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 22, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 22, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 21, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 19, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 19, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 19, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 21, 2024NON-FINAL ACTION E-MAILED
Wednesday, August 21, 2024NON-FINAL ACTION WRITTEN